The Survey of Fungal Wounds Infections in Burn Patients in Isfahan, Iran

Document Type : Original Article (s)

Authors

1 MSc Student, Department of Mycology and Parasitology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Professor, Department of Mycology and Parasitology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Assistant Professor, Department of Mycology and Parasitology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 Infectious Disease Specialist, Imam Mousa Kazem Burn Center, Isfahan, Iran

Abstract

Background: Bacteria, fungi, and viruses have the ability to colonize in burned lesions. Due to the wide use of antibacterial drugs, this colonization is increasing.These drugs induce impairment of immune system in burn patients, destruction of blood vessels, and presence of fungal agents in environment and body normal flora, colonization of fungi tends to induction of infection. The most common fungi in burn patients are Candida spp., Aspergillus spp., and other molds such as Mucorals. Nowadays, antifungals drugs cause resistance increasing in non-albicans spp., uncommon molds, and yeasts. This study aimed to determine fungal infections in burn patients.Methods: From 111 hospitalized burn patients at Isfahan burn center, Iran, during February 2016 to April 2017, sampling was performed via pus swabs and skin scraping. Each sample divided into two parts; one for direct exam by 10% potassium hydroxide (KOH) and Giemsa staining. The second part cultured on Sabouraud dextrose agar with chloramphenicol (SC); then, incubated at 30°C for 24-48 hours, and after amplification, the polymerase chain reaction (PCR) product was purified and sent for DNA sequencing.Findings: Out of 111 patients, only one specimen was positive in direct exam, culture criteria, and DNA sequencing, in which, Neurospora sitophila isolated and identified. In the present study, the frequency of fungal species was 0.9%.Conclusion: Due to the consideration of antifungals at the early phase after burn injury, the low positive rate of fungal cultures is reasonable. This prophylaxis protocol is recommended to be considered in other burn centers.

Keywords


  1. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev 2006; 19(2): 403-34.
  2. Hettiaratchy S, Dziewulski P. ABC of burns: pathophysiology and types of burns. BMJ 2004; 328(7453): 1427-9.
  3. Evers LH, Bhavsar D, Mailander P. The biology of burn injury. Exp Dermatol 2010; 19(9): 777-83.
  4. Bhat VG, Vasaikar SD. Bacteriological profile and antibiogram of aerobic burn wound isolates in Mthatha, Eastern Cape, South Africa. South Afr J Epidemiol Infec 2010; 25(4): 16-9.
  5. Mayhall CG. The epidemiology of burn wound infections: then and now. Clin Infect Dis 2003; 37(4): 543-50.
  6. Weber J, McManus A. Infection control in burn patients. Burns 2004; 30(8): A16-A24.
  7. de Macedo JL, Santos JB. Bacterial and fungal colonization of burn wounds. Mem Inst Oswaldo Cruz 2005; 100(5): 535-9.
  8. Struck MF, Gille J. Fungal infections in burns: a comprehensive review. Ann Burns Fire Disasters 2013; 26(3): 147-53.
  9. Luo G, Tan J, Peng Y, Wu J, Huang Y, Peng D, et al. Guideline for diagnosis, prophylaxis and treatment of invasive fungal infection post burn injury in China 2013. Burns Trauma 2014; 2(2): 45-52.
  10. Taneja N, Emmanuel R, Chari PS, Sharma M. A prospective study of hospital-acquired infections in burn patients at a tertiary care referral centre in North India. Burns 2004; 30(7): 665-9.
  11. Fayazov AD, Shukurov SI, Shukurov BI, Sultanov BC, Namazov AN, Ruzimuratov DA. Disorders of the immune system in severely burned patients. Ann Burns Fire Disasters 2009; 22(3): 121-30.
  12. Coban YK. Infection control in severely burned patients. World J Crit Care Med 2012; 1(4): 94-101.
  13. Lari AR, Alaghehbandan R. Nosocomial infections in an Iranian burn care center. Burns 2000; 26(8): 737-40.
  14. Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, Herndon DN. Emerging infections in burns. Surg Infect (Larchmt) 2009; 10(5): 389-97.
  15. Ramage G, Williams C. The clinical importance of fungal biofilms. Adv Appl Microbiol 2013; 84: 27-83.
  16. Lotfi N, Shokohi T. A review on fungal infection in burn patients, diagnosis and treatment. J Mazandaran Univ Med Sci 2014; 23(108): 151-65. [In Persian].
  17. Howard PA, Cancio LC, McManus AT, Goodwin CW, Kim SH, Pruitt BA. What's new in burn-associated infections? Current Surgery 1999; 56(7): 397-405.
  18. Capoor MR, Sarabahi S, Tiwari VK, Narayanan RP. Fungal infections in burns: Diagnosis and management. Indian J Plast Surg 2010; 43(Suppl): S37-S42.
  19. Kyriopoulos EJ, Kyriakopoulos A, Karonidis A, Gravvanis A, Gamatsi I, Tsironis C, et al. Burn injuries and soft tissue traumas complicated by mucormycosis infection: A report of six cases and review of the literature. Ann Burns Fire Disasters 2015; 28(4): 280-7.
  20. Vesty A, Biswas K, Taylor MW, Gear K, Douglas RG. Evaluating the Impact of DNA Extraction Method on the Representation of Human Oral Bacterial and Fungal Communities. PLoS One 2017; 12(1): e0169877.
  21. Sambrook J, Russell DW. Purification of nucleic acids by extraction with phenol:chloroform. CSH Protoc 2006; 2006(1).
  22. Zarrin M, Ganj F, Faramarzi S. Analysis of the rDNA internal transcribed spacer region of the Fusarium species by polymerase chain reaction-restriction fragment length polymorphism. Biomed Rep 2016; 4(4): 471-4.
  23. Zarrin M, Erfaninejad M. Molecular variation analysis of Aspergillus flavus using polymerase chain reaction-restriction fragment length polymorphism of the internal transcribed spacer rDNA region. Exp Ther Med 2016; 12(3): 1628-32.
  24. Luque EM, Gutierrez G, Navarro-Sampedro L, Olmedo M, Rodriguez-Romero J, Ruger-Herreros C, et al. A relationship between carotenoid accumulation and the distribution of species of the fungus Neurospora in Spain. PLoS One 2012; 7(3): e33658.
  25. Kuo HC, Hui S, Choi J, Asiegbu FO, Valkonen JP, Lee YH. Secret lifestyles of Neurospora crassa. Sci Rep 2014; 4: 5135.
  26. Perkins DD, Turner BC. Neurospora from natural populations: Toward the population biology of a haploid eukaryote. Exp Mycol 1988; 12(2):
  27. -131.
  28. Hood SV, Moore CB, Denning DW. Neurospora sitophila pulmonary infection in a patient with AIDS. AIDS Patient Care STDS 1997; 11(4): 223-6.
  29. Theodore FH, Littman ML, Almeda E. Endophthalmitis following catarct extraction due to Neurospora sitophila, a so-called nonpathogenic fungus. Am J Ophthalmol 1962; 53: 35-9.
  30. Radix AE, Bieluch VM, Graeber CW. Peritonitis caused by Monilia sitophila in a patient undergoing peritoneal dialysis. Int J Artif Organs 1996; 19(4): 218-20.
  31. Moreno-Ancillo A, Vicente J, Gomez L, Martin Barroso JA, Barranco P, Cabanas R, et al. Hypersensitivity pneumonitis related to a covered and heated swimming pool environment. Int Arch Allergy Immunol 1997; 114(2): 205-6.
  32. Ballard J, Edelman L, Saffle J, Sheridan R, Kagan R, Bracco D, et al. Positive fungal cultures in burn patients: A multicenter review. J Burn Care Res 2008; 29(1): 213-21.
  33. Luo G, Peng Y, Yuan Z, Cheng W, Wu J, Fitzgerald M. Yeast from burn patients at a major burn centre of China. Burns 2011; 37(2): 299-303.
  34. Rafiei A, Hemadi A, Hamzehlooie F. Determination of fungal colonization among burn patients reffered to Taleghani hospital, Ahwaz. Iran J Infect Dis Trop Med 2006; 11(34): 41-4. [In Persian].
  35. Gupta N, Haque A, Lattif AA, Narayan RP, Mukhopadhyay G, Prasad R. Epidemiology and molecular typing of Candida isolates from burn patients. Mycopathologia 2004; 158(4): 397-405.
  36. Rafik A, Diouri M, Bahechar N, Chlihi A. Epidemiology of nosocomial fungal infections in the National Center for Burns in Casablanca, Morocco. Ann Burns Fire Disasters 2016; 29(2): 90-3.
  37. Cen H, Wu Z, Wang F, Han C. Pathogen distribution and drug resistance in a burn ward: a three-year retrospective analysis of a single center in China. Int J Clin Exp Med 2015; 8(10): 19188-99.